--- title: "City Therapeutics hits 52-week low" type: "News" locale: "en" url: "https://longbridge.com/en/news/304300907.md" description: "City Therapeutics fell 2.06% to US$18.69. Down 13.64% over five sessions and up 3.88% from IPO price." datetime: "2026-11-04T14:44:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304300907.md) - [en](https://longbridge.com/en/news/304300907.md) - [zh-HK](https://longbridge.com/zh-HK/news/304300907.md) generator: "portal-rs" --- # City Therapeutics hits 52-week low City Therapeutics (CTY.US) fell more than **2%** during regular trading to **$18.69**, hitting a 52-week low intraday. The stock is down 13.64% over the past five sessions and up 3.88% from its IPO price. It sits 21.73% below its 52-week high of US$23.88. Volume was 9.17 times its average. The Nasdaq Composite is down 2.47% over the past five sessions and up 11.42% year to date. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [CTY.US](https://longbridge.com/en/quote/CTY.US.md) ## Related News & Research - [AI Payroll Rollout Could Be A Game Changer For Workday (WDAY)](https://longbridge.com/en/news/306350754.md) - [CAPR: FDA issued a CRL for Deramiocel, citing insufficient evidence of effectiveness](https://longbridge.com/en/news/306366333.md) - [Is it time to buy at the bottom? Jensen Huang is still being smeared. Anthropic's IPO = a horror story.](https://longbridge.com/en/news/306347695.md) - [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md) - [Zoomability Announces Availability of Q3 2026 Report](https://longbridge.com/en/news/306354193.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**